CRi Announces ISO Certification

December 29, 2008

CRi Announces ISO 9001:2000 Certification

Woburn, Massachusetts – December 29, 2008

Woburn, MA-December 29, 2008. Cambridge Research & Instrumentation, Inc (CRi) announced today that the company has received ISO 9001:2000 certification. The ISO 9001 series of standards was written to provide guidelines to assist organizations implement and operate quality management systems. The current series of standards are internationally accepted and provide a consistent basis for understanding requirements relating to product and service quality.

“CRi operations are controlled and performed in a systematic and logical manner for maximum efficiency and effectiveness. The most successful companies in the world benefit from implementing systems that not only provide a framework for continuous process improvement, but also addressing the needs of their customers,” says Lou Spiridigliozzi, Vice President of Operations at CRi.

CRi manufactures sophisticated imaging systems for life scienceapplications, as well as components for OEMs manufacturing their own specialized systems. The company partnered with International Management Systems Marketing (IMSM), a recognized leader in international externally audited standards in order to validate existing documentation, as well as to further document new procedures in order to achieve auditable results.

“Customers are increasingly quality-conscious. They expect that manufacturers pro-actively comply with the highest product and service quality standards, assuring that we will continue to meet their needs now and in the long term,” said George Abe, President and CEO. “While CRi has always delivered quality products, we felt it was time to obtain formal ISO certification as part of our long term commitment to our customers”.

–

Cambridge Research & Instrumentation, Inc (CRi) is a Boston-based biomedical imaging company providing innovative optical imaging solutions for more than 20 years. CRi’s multidisciplinary team is dedicated to providing comprehensive solutions that enable customers to produce breakthroughs in research and medical care. CRi technology helps extract new disease-specific information from biological and clinical samples in the physiological, morphological, and biochemical context of intact tissues and organisms.

With over 80 patents pending and issued, CRi’s award-winning innovations are being utilized around the world in a wide range of settings, ranging from academic researcher to pharmaceutical drug development to clinical medicine. CRi is headquartered in Woburn, Massachusetts, and operates a state-of-the-art manufacturing facility and is able to rapidly design and manufacture system-level solutions for a variety of growing market applications.

For more information visit our website at www.cri-inc.com or contact:

Ross Nakatsuji

CRi Marketing/Sales Group Leader

35-B Cabot Road, Woburn, MA 01801 USA

(P) 1-781-935-9099, extension 177, (C) 1-781-405-4000, (E) rnakatsuji@cri-inc.com